Back

Enhanced iPSC-Cardiomyocyte Maturation via Combined 3D-Culture and Metabolic Cues

Rebs, S.; Eberl, H.; Wagensohner, N.; Dybkova, N.; Unsoeld, J. K.; Dudek, J.; Costa, P. M.; Fernandez, M. C.; Rog-Zielinska, E. A.; Schneider-Warme, F.; Maack, C.; Sossalla, S.; Streckfuss-Boemeke, K.

2025-10-30 cell biology
10.1101/2025.10.29.684362 bioRxiv
Show abstract

Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) have become an invaluable tool for disease modelling and drug testing. However, while many etiologies of heart failure involve defects in excitation-contraction coupling, mitochondrial energetics or both, iPSC-CM are limited by the developmental immaturity of these processes. Here, we report a combinatorial strategy to enhance the maturation of human iPSC-CM by integrating three-dimensional (3D) spheroid culture conditions with a defined hormone- and fatty acid-enriched maturation medium (MM). A comprehensive analysis of structural, electrophysiological and Ca2+ handling parameters was performed to evaluate cellular and functional maturation. The iPSC-CM generated under these conditions (3D_MM) exhibit many phenotypic characteristics that resemble those of isolated adult human CM, including (i) a rod-shaped morphology, (ii) cardiac ultrastructural features such as aligned myofilaments, unidirectional organized sarcomeres, and the presence of transverse (t)-tubules, (iii) refined action potential (AP) parameters and Ca2+ handling, and (iv) {beta}-adrenergic responsiveness and a positive force-frequency relationship. Compared with long-term (LT) monolayer cultures of 90 days or the individual cues (3D or MM alone), the 3D_MM protocol achieves mostly superior or at the least non-inferior maturation effects. This systematic investigation further demonstrates that while 3D culturing or MM alone improved specific aspects of maturation, only their synergistic combination produced a comprehensive enhancement of key CM processes, such as excitation-contraction coupling and mitochondrial energetics.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Molecular and Cellular Cardiology
40 papers in training set
Top 0.1%
12.0%
2
Stem Cell Reports
130 papers in training set
Top 0.2%
9.8%
3
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
7.9%
4
Cells
249 papers in training set
Top 0.2%
6.8%
5
Stem Cells Translational Medicine
13 papers in training set
Top 0.1%
6.8%
6
Stem Cell Research
16 papers in training set
Top 0.1%
6.3%
7
Stem Cells
31 papers in training set
Top 0.1%
4.3%
50% of probability mass above
8
Scientific Reports
3612 papers in training set
Top 30%
3.5%
9
American Journal of Physiology-Cell Physiology
39 papers in training set
Top 0.2%
3.3%
10
PLOS ONE
5266 papers in training set
Top 37%
3.2%
11
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 1%
2.8%
12
Experimental Cell Research
28 papers in training set
Top 0.2%
2.1%
13
Biomaterials
84 papers in training set
Top 0.8%
1.9%
14
iScience
1154 papers in training set
Top 16%
1.7%
15
International Journal of Molecular Sciences
494 papers in training set
Top 9%
1.5%
16
eLife
5828 papers in training set
Top 52%
1.5%
17
Cell Death & Disease
126 papers in training set
Top 2%
1.4%
18
Advanced Healthcare Materials
85 papers in training set
Top 1%
1.4%
19
Cell Proliferation
12 papers in training set
Top 0.2%
1.1%
20
Cardiovascular Research
37 papers in training set
Top 1%
0.8%
21
Toxicology and Applied Pharmacology
14 papers in training set
Top 0.4%
0.6%
22
Toxicological Sciences
41 papers in training set
Top 0.6%
0.6%
23
Advanced Science
286 papers in training set
Top 11%
0.6%
24
Tissue Engineering Part A
15 papers in training set
Top 0.3%
0.6%
25
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.6%
26
American Journal of Physiology-Heart and Circulatory Physiology
36 papers in training set
Top 1%
0.6%
27
Frontiers in Bioengineering and Biotechnology
98 papers in training set
Top 3%
0.6%
28
Journal of Cellular Physiology
25 papers in training set
Top 0.9%
0.6%